Jefferies Group LLC Vanda Pharmaceuticals Inc. Put Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $119,240 - $182,050	-11,000 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$15.69 - $21.14 $213,384 - $287,504	-13,600 Reduced 55.28%	11,000 $172,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $213,384 - $287,504	-13,600 Reduced 55.28%	11,000 $173,000
Q3 2021 Sep 21, 2023	BUY	$15.35 - $21.27 $377,610 - $523,242	24,600 New	24,600 $421,000
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $377,610 - $523,242	24,600 New	24,600 $422,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $282M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.